Welcome to our dedicated page for Emerson Elec Co SEC filings (Ticker: EMR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Emerson Electric’s global automation empire spans petrochemical valves, DeltaV control software, and measurement devices in more than 150 countries—so it’s no surprise the company’s 10-K stretches past 300 pages. Finding backlog trends, segment margins, or divestiture impacts inside those dense reports can strain even seasoned analysts.
Stock Titan’s AI-powered analysis turns that complexity into clarity. Need the next Emerson Electric quarterly earnings report 10-Q filing? We post it the moment EDGAR does and supply a plain-English summary that flags order growth, supply-chain costs, and factory-automation demand. Watching executive moves? Our real-time alerts surface every Emerson Electric insider trading Form 4 transactions entry, so you can track Emerson Electric executive stock transactions Form 4 before material announcements land in an 8-K.
Whether you’re asking “How do I read Emerson Electric’s annual report 10-K simplified?� or “Where are Emerson Electric proxy statement executive compensation figures?�, you’ll find the answer here. Coverage includes:
- 10-K and 10-Q filings with AI summaries that explain segment performance and backlog shifts
- 8-K material events explained in context of plant expansions, M&A, or cyber incidents
- Emerson Electric Form 4 insider transactions real-time with pattern analysis
- DEF 14A proxy details on executive pay and say-on-pay votes
Stop wading through engineering jargon. With Stock Titan you can compare quarter-over-quarter revenue, monitor Emerson Electric earnings report filing analysis, and understand regulatory risks—all in minutes, not hours. Understanding Emerson Electric SEC documents with AI has never been this straightforward.
Emerson Electric (EMR) Q3-25 10-Q highlights:
- Net sales rose 4% YoY to $4.55 bn; underlying growth +3% (price +2.5 ppts, volume +0.5 ppt).
- Diluted EPS from continuing ops surged 72% to $1.03, aided by the absence of last year’s $0.38 Copeland note loss; adjusted EPS up 6% to $1.52.
- Segment mix: Intelligent Devices sales +4% (margin 22.5%), Software & Control +3% (margin 16.7%); Test & Measurement loss narrowed sharply ($-26 m vs $-88 m).
- YTD (9 mo) sales +2% to $13.16 bn; diluted EPS $2.91 vs $1.84. Gross margin improved 260 bp to 53.2% on lower purchase-accounting amortization and pricing.
- AspenTech consolidation: on 12 Mar 25 EMR bought remaining AspenTech shares for ~$7.2 bn; AspenTech now in Control Systems & Software. Deal drove $7.2 bn equity reduction, $1.5 bn new long-term notes and $5.4 bn commercial paper.
- Balance sheet shifts: Cash fell to $2.2 bn (-$1.4 bn YTD); short-term borrowings jumped to $6.0 bn; net debt/EBITDA pro-forma ~2.6Ă—. Equity down to $19.9 bn from $27.5 bn as NCI largely eliminated.
- Operating cash flow modestly lower at $2.09 bn (-7% YoY); capex $263 m; financing outflow $3.0 bn (buybacks, dividends, AspenTech purchase).
- Backlog stands at $8.9 bn; 75% expected to convert within 12 months.
- Effective tax rate Q3 21% (up 200 bp) and YTD 25% (up 500 bp) due to AspenTech-related discrete items.
Key takeaways: Emerson delivered solid topline and adjusted profit growth while integrating AspenTech, but leverage, lower cash and higher taxes temper the near-term outlook.
FAQ
What is the current stock price of Emerson Elec Co (EMR)?
What is the market cap of Emerson Elec Co (EMR)?
